{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:37:43Z","timestamp":1733877463186,"version":"3.30.1"},"reference-count":4,"publisher":"Medknow","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["smedj"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.11622\/smedj.2018057","type":"journal-article","created":{"date-parts":[[2018,5,28]],"date-time":"2018-05-28T07:13:18Z","timestamp":1527491598000},"page":"287-287","source":"Crossref","is-referenced-by-count":2,"title":["Comment on: Medication-related osteonecrosis of the jaw in osteoporotic patients: prevention and management"],"prefix":"10.4103","volume":"59","author":[{"given":"CL","family":"Toh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Dutton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2581","published-online":{"date-parts":[[2018,5]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"70","DOI":"10.11622\/smedj.2018014","article-title":"Medication-related osteonecrosis of the jaw in osteoporotic patients: prevention and management","volume":"59","author":"Chan","year":"2018","unstructured":"1. Chan BH, Yee R, Puvanendran R, Ang SB. Medication-related osteonecrosis of the jaw in osteoporotic patients: prevention and management. Singapore Med J 2018; 59:70-5.","journal-title":"Singapore Med J"},{"key":"ref1","unstructured":"1. American Association of Oral and Maxillofacial Surgeons. Position Paper: Medication-Related Osteonecrosis of the Jaw\u20142014 Update [online]. Available at: https:\/\/www.aaoms.org\/docs\/govt_affairs\/advocacy_white_papers\/mronj_position_paper.pdf. Accessed April 18, 2018."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.3899\/jrheum.100221","article-title":"Bisphosphonate-associated osteonecrosis of the jaw in Ontario: a survey of oral and maxillofacial surgeons","volume":"38","author":"Khan","year":"2011","unstructured":"3. Khan AA, Rios LP, S\u00e1ndor GK, et al. Bisphosphonate-associated osteonecrosis of the jaw in Ontario: a survey of oral and maxillofacial surgeons. J Rheumatol 2011; 38:1396-402.","journal-title":"J Rheumatol"},{"key":"ref3","first-page":"1391","article-title":"Canadian Association of Oral and Maxillofacial Surgeons. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.","volume":"35","author":"Khan","year":"2008","unstructured":"4. Khan AA, S\u00e1ndor GK, Dore E, et al; Canadian Association of Oral and Maxillofacial Surgeons. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. J Rheumatol 2008; 35:1391-7.","journal-title":"J Rheumatol","ISSN":"https:\/\/id.crossref.org\/issn\/0315-162X","issn-type":"print"}],"container-title":["Singapore Medical Journal"],"original-title":[],"link":[{"URL":"http:\/\/www.smj.org.sg\/article\/comment-medication-related-osteonecrosis-jaw-osteoporotic-patients-prevention-and-management","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T10:53:54Z","timestamp":1660042434000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.smj.org.sg\/article\/comment-medication-related-osteonecrosis-jaw-osteoporotic-patients-prevention-and-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":4,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5]]},"published-print":{"date-parts":[[2018,5]]}},"URL":"https:\/\/doi.org\/10.11622\/smedj.2018057","relation":{},"ISSN":["0037-5675"],"issn-type":[{"type":"print","value":"0037-5675"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}